BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10963578)

  • 1. Lipid lunch for persistent pathogen.
    Bishai W
    Nature; 2000 Aug; 406(6797):683-5. PubMed ID: 10963578
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
    Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiology. A weak link in TB bacterium is found.
    Helmuth L
    Science; 2000 Aug; 289(5482):1123-5. PubMed ID: 10970221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
    Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
    Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis: here today, and here tomorrow.
    Russell DG
    Nat Rev Mol Cell Biol; 2001 Aug; 2(8):569-77. PubMed ID: 11483990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof].
    Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis.
    Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C
    Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
    Nandakumar M; Nathan C; Rhee KY
    Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who puts the tubercle in tuberculosis?
    Russell DG
    Nat Rev Microbiol; 2007 Jan; 5(1):39-47. PubMed ID: 17160001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension.
    Tsai MC; Chakravarty S; Zhu G; Xu J; Tanaka K; Koch C; Tufariello J; Flynn J; Chan J
    Cell Microbiol; 2006 Feb; 8(2):218-32. PubMed ID: 16441433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets.
    Singh VK; Ghosh I
    Theor Biol Med Model; 2006 Aug; 3():27. PubMed ID: 16887020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection.
    Stewart GR; Snewin VA; Walzl G; Hussell T; Tormay P; O'Gaora P; Goyal M; Betts J; Brown IN; Young DB
    Nat Med; 2001 Jun; 7(6):732-7. PubMed ID: 11385512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages.
    Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N
    Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocitrate lyase encoding plasmids in BCG cause increased survival in ApoB100-only LDLR-/- mice.
    Szabo AM; Endresz V; Somogyvari F; Miczak A; Faludi I
    Mol Biol Rep; 2013 Aug; 40(8):4721-5. PubMed ID: 23653002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting isocitrate lyase for the treatment of latent tuberculosis.
    Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
    Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.
    Gould TA; van de Langemheen H; Muñoz-Elías EJ; McKinney JD; Sacchettini JC
    Mol Microbiol; 2006 Aug; 61(4):940-7. PubMed ID: 16879647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
    Zhou M; Xie L; Yang Z; Zhou J; Xie J
    J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TB research; entering the post-genomic era.
    Young DB
    Mol Med Today; 1997 Jan; 3(1):6-7. PubMed ID: 9021735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.